FIV Vif Antibodies

Santa Cruz Biotechnology offers a broad range of FIV Vif monoclonal antibodies for studying feline immunodeficiency virus (FIV) and viral protein Vif. FIV Vif monoclonal antibodies support multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). FIV Vif protein counteracts host antiviral responses, enabling viral replication and persistence within infected cells. Understanding FIV Vif functionality remains crucial for developing effective treatments against FIV infections that significantly impact feline health. Research focusing on FIV Vif helps illuminate viral mechanisms and potential therapeutic targets. Investigating FIV Vif interactions with host cellular factors provides valuable information about viral immune evasion strategies. Detailed analysis of FIV Vif expression patterns throughout infection stages enhances knowledge of disease progression. Exploring FIV Vif's molecular characteristics advances both basic virology research and clinical applications. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of FIV and developing improved treatments for feline viral diseases.